Investment Rating - The investment rating for the company is "Buy-A" with a 6-month target price of 46.86 CNY [4]. Core Insights - The company has shown a steady increase in revenue and profit, with a notable growth in high-end product sales, which accounted for 29% of revenue in Q1 2025, up from 24% in 2024 [2][3]. - High-end products have seen significant growth in both volume and price, with Q1 2025 revenue from high-end products increasing by 86.60% year-on-year, and sales of products priced above 50,000 CNY growing by 89.93% [2][3]. - The company maintains a high level of R&D investment, with R&D expenses reaching 1.08 billion CNY in 2024, representing a 26% increase year-on-year, and a R&D expense ratio of 21.81% [3]. Financial Performance - In 2024, the company achieved a revenue of 497.4 million CNY, a year-on-year increase of 2.93%, while the net profit decreased by 27.79% to 112.1 million CNY [1][8]. - For Q1 2025, the company reported a revenue of 132 million CNY, a 26.93% increase year-on-year, and a net profit of 41 million CNY, up 33.96% [1]. - The company forecasts revenue growth to 603.7 million CNY in 2025, with a projected net profit of 149 million CNY [9]. Product Development - The company has launched 10 new products in 2024, including high-end digital oscilloscopes and signal generators, which are expected to drive further revenue growth [3]. - The continuous introduction of high-end products is a key factor supporting the company's stable performance [3]. Market Position - The company is recognized as a leading manufacturer of general electronic testing and measurement instruments in China, with a strong focus on high-end product development [3][4].

Investment Rating - The report maintains an investment rating of "Outperform the Market - B" for the construction industry [4]. Core Insights - The construction industry is currently under pressure, with revenue and net profit declining year-on-year. However, there are expectations for policy support and investment increases, particularly in infrastructure, which may improve the industry's fundamentals [17][18]. - The report highlights the potential for significant investment demand driven by urbanization and infrastructure upgrades, estimating a need for approximately 4 trillion yuan in investment over the next five years for urban underground pipeline renovations [16]. - The report suggests focusing on traditional state-owned enterprises in construction, which are currently undervalued and may benefit from improved financial metrics and increased infrastructure spending [11][12]. Summary by Sections Industry Dynamics Analysis - The construction sector is facing operational challenges in 2024 and Q1 2025, with revenue and net profit both experiencing year-on-year declines of 3.89% and 15.98% respectively in 2024, and 6.27% and 8.54% in Q1 2025 [17][19]. - The report emphasizes the importance of expanding domestic demand as a key support for economic growth amid external pressures such as tariffs from the U.S. [17]. Market Performance - The construction and decoration industry saw a decline of 1.26% in the week from April 28 to April 30, underperforming compared to major indices [46]. - The report notes that while the overall industry is struggling, certain segments like landscaping engineering have shown positive performance [46]. Company Announcements - The report includes a summary of major order announcements from companies within the industry, indicating ongoing activity despite the challenging environment [58]. Key Focus Stocks - The report identifies several key stocks to watch, including major state-owned construction firms and companies involved in infrastructure design and international engineering services, which are expected to benefit from increased investment and policy support [11][12][57].

Investment Rating - The investment rating for the company is "Buy-A" with a 6-month target price of 9.08 CNY, compared to the current stock price of 7.81 CNY as of April 30, 2025 [5]. Core Views - The company's Q1 2025 revenue was 256.76 billion CNY, a year-on-year decrease of 6.61%, primarily due to weak demand in traditional business sectors. The net profit attributable to shareholders was 5.15 billion CNY, down 14.51% year-on-year, with a decline in gross margin contributing to the profit drop [2][3]. - Despite the revenue and profit decline, the company has a solid order backlog of 7.86 trillion CNY, approximately 7.4 times its 2024 revenue, indicating a strong foundation for future revenue growth [2]. - The company signed new contracts worth 492.84 billion CNY in Q1 2025, with a notable increase in overseas contracts by 30.10% year-on-year, while domestic contracts decreased by 13.17% [4]. Summary by Sections Financial Performance - In Q1 2025, the company experienced a gross margin decline of 0.28 percentage points, leading to a sales net profit margin of 2.38%, down 0.20 percentage points year-on-year. The operating cash flow improved, with a net outflow of 38.95 billion CNY, which is 7.65 billion CNY less than the previous year [2][3]. Order and Contract Activity - The new contract value in Q1 2025 was 492.84 billion CNY, with domestic contracts at 448.68 billion CNY and overseas contracts at 44.16 billion CNY. The growth in the green environmental sector and railway engineering contracts was particularly strong, with increases of 77.05% and 66.25% year-on-year, respectively [4]. Earnings Forecast - The company’s revenue projections for 2025-2027 are 1.08 trillion CNY, 1.10 trillion CNY, and 1.11 trillion CNY, with expected year-on-year growth rates of 1.50%, 1.30%, and 1.30%. The net profit forecasts for the same period are 22.47 billion CNY, 22.73 billion CNY, and 22.99 billion CNY, with corresponding growth rates of 1.15% each year [9][10].

Investment Rating - The investment rating for Postal Savings Bank is "Buy-A" with a target price of 6.31 CNY over the next six months [5]. Core Views - The report highlights that the bank's revenue in Q1 2025 decreased by 0.07% year-on-year, while the pre-provision profit grew by 6.20%. However, the net profit attributable to shareholders fell by 2.62% year-on-year. The main drivers for performance were the expansion of interest-earning assets and cost reduction, while narrowing net interest margins and increased provisioning negatively impacted growth [1][11]. Summary by Sections Financial Performance - As of the end of Q1 2025, Postal Savings Bank's total assets grew by 8.31% year-on-year, with total loans increasing by 9.78% and financial investments by 9.45%. The bank added 604.5 billion CNY in total assets and 443 billion CNY in loans during the quarter [1]. - The bank's net interest margin for Q1 2025 was measured at 1.71%, down 21 basis points year-on-year and 10 basis points quarter-on-quarter, but still remains competitive within the industry [4][9]. - Non-interest income increased by 14.83% year-on-year, with net fees growing by 8.76% and investment income rising by 21.70% [10]. Loan Growth - Corporate loans saw a significant increase of 15.17% year-on-year, with a quarterly addition of 362 billion CNY, leading among major banks [2]. - Retail loans grew by 4.27% year-on-year, with a quarterly addition of 678 billion CNY, although this was a decrease compared to previous quarters [2]. Deposit Growth - Total deposits increased by 9.22% year-on-year, with corporate and retail deposits growing by 20.46% and 7.94% respectively. The bank focused on low-cost self-operated deposits, adding 141.7 billion CNY in corporate deposits during the quarter [3]. Asset Quality - The non-performing loan ratio stood at 0.91% at the end of Q1 2025, remaining stable. The provision coverage ratio was 266.13%, indicating a solid buffer against potential loan losses [10][11]. Future Outlook - The bank plans to enhance support for key sectors such as new productivity and inclusive small and micro enterprises, while also increasing consumer loan offerings in response to policy opportunities. The cost advantage on the liability side, combined with adjustments in agency fee rates, is expected to support performance [11].

Investment Rating - The investment rating for Chengdu Bank is "Accumulate-A" with a target price of 18.87 CNY over the next six months [4]. Core Views - Chengdu Bank has demonstrated robust growth in both asset scale and performance, with a revenue growth rate of 5.89% for 2024 and a net profit growth rate of 10.17% [1][9]. - The bank's performance is primarily driven by the expansion of interest-earning assets, although net interest margin compression has been a significant drag on growth in early 2025 [1][8]. - The bank is expected to maintain a stable performance due to its strong asset quality and sufficient provisioning, with projected revenue growth of 8.17% and profit growth of 9.25% for 2025 [9][10]. Summary by Sections Financial Performance - Chengdu Bank's total assets grew by 14.56% year-on-year by the end of 2024, with a quarterly increase of 285 billion CNY, while loans increased by 18.76% year-on-year [1][2]. - In Q1 2025, total assets increased by 13.25% year-on-year, with loans contributing significantly to this growth [1][2]. Loan Growth - Corporate loans showed steady growth, with balances increasing by 20.31% year-on-year by the end of 2024 and 17.69% year-on-year by the end of Q1 2025 [2]. - Retail loans also performed well, with year-on-year growth rates of 12.46% and 13.37% for 2024 and Q1 2025, respectively [3]. Asset Quality - Chengdu Bank maintained a low non-performing loan (NPL) ratio of 0.66% at the end of both 2024 and Q1 2025, indicating strong asset quality [9][10]. - The bank's provisioning coverage ratio was robust at 479.29% by the end of 2024 and 456.00% by the end of Q1 2025, reflecting its strong risk mitigation capabilities [9][10]. Non-Interest Income - Non-interest income showed a significant increase of 24.11% year-on-year in Q4 2024, primarily driven by investment income, although fee income declined [9][10]. Interest Margin - The net interest margin for 2024 was stable at 1.66%, but a significant decline is expected in Q1 2025 due to the impact of interest rate adjustments [8][9]. Future Outlook - The bank is expected to continue focusing on government-related financing while also responding to policy calls to enhance industrial demand and increase technology and green loan offerings in 2025 [2][9].

2025 年 05 月 05 日 招商银行(600036.SH) 事件：招商银行公布 2025 年一季报，营收同比增长-3.09%，拨 备前利润同比增长-4%，归母净利润同比增长-2.08%，各项业绩指 标增速较 2024 年报均略有下行，与 2024 年一季报情景较为类 似，我们点评如下： 招商银行 2025 年一季度业绩增长主要依靠规模扩张所驱动，而 净息差同比收窄、非息收入增长放缓则对利润增长形成拖累。 规模扩张速度与去年四季度大致相当。今年一季度，招商银行 生息资产（日均余额口径）同比增长 8.7%，较 2024Q4 增速基本 持平，仍处于去年初以来较快增长阶段，其中信贷增速基本平稳， 信贷扩张节奏仍偏低，而金融投资增速较 2024Q4 提升约 2 个百 分点，同业类资产增速略有放缓。从单季度新增生息资产规模（日 均余额口径）来看，今年 Q1 新增生息资产 1766 亿元，同比多增 84 亿元，其中新增信贷同比多增 62 亿元，而新增金融投资同比 多增 595 亿元。资产配置结构显示，当前有效信贷需求不足是资 产投放的核心矛盾。 进一步观察信贷结构，我们以招商银行本公司口径的期末时点数据进 行分析，一 ...

Investment Rating - The investment rating for the company is "Buy-A" with a 6-month target price of 32.79 CNY per share [4]. Core Views - The report indicates that the company has seen a recovery in sales, with April wholesale sales reaching 100,000 units, a year-on-year increase of 6% and a month-on-month increase of 2% [2]. - The company is entering a new growth phase, driven by new product launches and improved marketing strategies, which are expected to lead to an upward trend in sales [3]. - The report highlights the potential for significant profit elasticity due to the introduction of new models and advanced technologies [3]. Sales Performance - April sales were boosted by the accelerated delivery of the Tank 300 and the launch of the second-generation Xiaolong MAX, contributing to a year-on-year increase in sales [2]. - The company sold 29,000 new energy vehicles in April, representing a year-on-year increase of 28% and a month-on-month increase of 14% [2]. - The sales breakdown for April includes 57,000 units for Haval (up 21% year-on-year), 4,811 units for Wey (up 8% year-on-year), and 1,797 units for Ora (down 62% year-on-year) [2]. Financial Forecast - The company is projected to achieve net profits of 14.03 billion CNY, 17.40 billion CNY, and 20.96 billion CNY for the years 2025, 2026, and 2027, respectively [9]. - The expected price-to-earnings ratios for these years are 13.8, 11.1, and 9.2 times, indicating a favorable valuation trend [8][9]. - Revenue is forecasted to grow from 173.21 billion CNY in 2023 to 336.49 billion CNY by 2027, reflecting a compound annual growth rate [9][10]. Market Outlook - The mainstream market for new vehicles is expected to see an upward sales trend, supported by the successful launch of new models and enhanced marketing efforts [3]. - The company has a diverse product lineup and strong technological reserves, which position it well for future growth in both domestic and international markets [3]. - The report emphasizes the potential for the Hi4Z technology to expand the company's market share in the off-road segment, enhancing profitability [3].

4 月销量环比小幅下滑预计受终端需求与新老款交替影响，焕新版上市 在即、销量有望迎来向上拐点。 2025 年 05 月 05 日 理想汽车-W(02015.HK) 4 月销量符合预期，焕新版上市在即、销量拐点可期 事件：理想汽车发布公告，4 月交付量 3.4 万台，同比+32%，环比-7%。 1） 我们认为公司 4 月交付量同比提升主要系去年同期 L6 未开启大规模 交付；环比下滑预计系虽 4 月终端购车优惠及 3 年 0 息金融方案延续对销 量有拉动作用，但老款开始清库（L 系列老款部分配置、MEGA 老款下架）， 新老款交替对 4 月销量产生一定影响。 2） MEGA 焕新版销量有望持续突破：4 月 23 日，理想 MEGA Ultra 焕新版 &Home 家庭特别版正式上市，其中 Ultra 焕新版升级 ATL 全天候激光雷达、 Thor-U 芯片、副驾准零重力皇后座、21.4 英寸后舱娱乐屏等，Home 版在 此基础上升级了零重力旋转座椅、前排静音电关门等，产品力均有大幅提 升；同时随着超充站布局日益完善（截至 4 月底已布局超充站 2267 个、充 电桩 12340 个）、产品口碑逐渐积累、营销思路 ...

Investment Rating - The investment rating for the company is "Buy-A" with a 6-month target price of 263.83 CNY [4][10]. Core Views - The company reported a revenue of 36.726 billion CNY in 2024, representing a year-on-year growth of 5.14%, while the net profit attributable to shareholders was 11.668 billion CNY, a growth of 0.74% [1]. - The first quarter of 2025 showed a revenue of 8.237 billion CNY, a year-on-year decline of 12.12% but a quarter-on-quarter increase of 13.76% [1]. - The recovery in bidding activities since the end of 2024 is expected to gradually improve the company's performance [2]. - The company is positioned as a leader in industry digitalization, leveraging AI to enhance business expansion and innovate its business model [4][9]. Financial Performance Summary - In 2024, the company's revenue from life information and support business was 13.557 billion CNY, down 11.11% year-on-year, while the minimally invasive surgery segment grew over 30% [3]. - The in-vitro diagnostics business generated 13.765 billion CNY in 2024, marking a year-on-year increase of 10.82% [3]. - The medical imaging business achieved a revenue of 7.498 billion CNY in 2024, with international sales growing over 15% [3]. - The company expects revenue growth rates of 10.5%, 15.5%, and 14.6% for 2025 to 2027, respectively, with net profit growth rates of 9.7%, 15.3%, and 15.0% [10].

2025 年 05 月 05 日 生物医药Ⅱ 新药周观点：25Q1 创新药板块持仓环 比大幅提升 本周新药行情回顾： 2025 年 4 月 28 日-2025 年 5 月 2 日，新药板块涨幅前 5 企业：艾迪 药业（19.49%）、科伦博泰生物（17.02%）、乐普生物（16.09%）、 康诺亚（13.61%）、康宁杰瑞（13.60%）；跌幅前 5 企业：康方生物 （-11.22%）、宜明昂科（-10.03%）、东耀药业（-6.90%）、迈博药 业（-6.52%）、亚盛医药（-5.63%）。 本周新药行业重点分析： 根据最新披露的基金 2025 年第一季度报告，我们统计分析了全部所 有基金截止 2025 年 3 月 31 日对于创新药板块的最新重仓持仓情况 （注：在此仅统计了 A 股、港股 Biotech 创新药公司的基金重仓持 仓，对于以恒瑞医药为首的传统转型创新药企业未纳入统计；此外由 于基金季报仅披露重仓持仓情况，因此可能无法完全体现基金对创新 药板块的持仓情况）。 行业周报 证券研究报告 投资评级 领先大市-A 维持评级 | | | 行业表现 资料来源：Wind 资讯 升幅% 1M 3M 12M 相 ...